与新型冠状病毒肺炎相关的米勒-费雪综合征

Yaqoob Arjimand, Dar Waseem, Khuja Zubair, Bukhari Immia, Raina Adnan, Ganie Hilal, Chandra Amit, Wani Maqbool, Asimi Ravouf, Wani Faizan

Department of Neurology, SKIMS, Jammu and Kashmir, India.

Department of General Medicine, SKIMS, Jammu and Kashmir, India.

J Family Med Prim Care. 2022 Jul;11(7):4023-4025. doi: 10.4103/jfmpc.jfmpc_1864_21. Epub 2022 Jul 22.

Miller Fisher syndrome (MFS), is an acute peripheral neuropathy, a variant of Guillain-Barre syndrome, that develops following exposure to different viral, bacterial, and fungal pathogens. Patients usually present with a triad of ophthalmoplegia, ataxia, and areflexia. During Covid pandemic MFS has been described associated with novel coronavirus disease 2019 (COVID-19). Here we describe the clinical course, Cerebrospinal fluid (CSF) findings, nerve conduction studies, treatment and outcome of the patient having MFS concurrent with COVID 19.

米勒-费雪综合征（MFS）是一种急性周围神经病，是吉兰-巴雷综合征的一种变体，在接触不同的病毒、细菌和真菌病原体后发病。患者通常表现为眼肌麻痹、共济失调和腱反射消失三联征。在新冠疫情期间，已发现MFS与2019年新型冠状病毒病（COVID-19）有关。在此，我们描述了一名同时患有MFS和COVID-19患者的临床病程、脑脊液（CSF）检查结果、神经传导研究、治疗及预后情况。